wve-120102
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 17, 2017 (NCT03225846)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- HuntingtinINHIBITOR
HTT inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04617860 | Phase 1/Phase 2 (Phase 2) | Sep 24, 2019 | Wave Life Sciences |
| NCT03225846 | Phase 1/Phase 2 (Phase 2) | Jul 17, 2017 | Wave Life Sciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Wave Life Sciences | For profit | 2 | 2 | 1 | 2017 |
1 organizations
Page 1 / 1